Lung cancer can affect individuals regardless of age or smoking history, yet public perception often leads to delayed diagnoses and stigma.

Up to 20% of lung cancer cases in the United States occur in people who have never smoked. Healthline Editor-in-Chief Robin Hough interviewed Gini Harrison, a professor and lung cancer patient, to discuss the importance of recognizing symptoms that do not fit traditional expectations of the disease.

Challenging Public Perceptions

Gini Harrison, a psychologist and trustee of EGFR Positive Lung Cancer UK, was diagnosed with stage 4 EGFR-positive lung cancer in December 2021. Her initial symptom was shoulder pain, which was incorrectly attributed to breastfeeding posture for months. Harrison emphasizes that lung cancer symptoms can be non-respiratory and that patients should be listened to when symptoms persist or worsen.

The Role of Biomarker Testing

Biomarker testing identifies specific genetic mutations, such as EGFR, that drive tumor growth. Understanding these mutations allows for targeted treatment options. Harrison notes that these mutations typically develop over a person's lifetime rather than being inherited, and she advocates for broader awareness of these tests.

Documenting the Reality of Lung Cancer

The documentary 'Our Lungs: Time to Breathe,' commissioned by EGFR Positive Lung Cancer UK, features the stories of filmmaker Sarah Li and Alex, a 24-year-old soccer player who died weeks after his diagnosis. The film aims to challenge the narrow public image of lung cancer and highlight the critical need for earlier detection.